MESALAMINE 1.2 g/1
mesalamine · TABLET, DELAYED RELEASE · Lannett Company Inc.
No Recall History
Plain English
MESALAMINE is a tablet, delayed release containing mesalamine at 1.2 g/1, taken oral. Manufactured by Lannett Company Inc..
Key Facts
- Brand Name
- MESALAMINE
- Generic Name
- mesalamine
- NDC Code (Product)
0527-3012- Manufacturer
- Lannett Company Inc.
- Strength
- 1.2 g/1
- Dosage Form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA217337
- Drug Class
- Aminosalicylate [EPC]
- Marketing Start
- 06/03/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
off label use6,239 reports
colitis ulcerative4,341 reports
drug ineffective4,187 reports
condition aggravated3,232 reports
diarrhoea2,508 reports
haematochezia2,348 reports
fatigue2,108 reports
abdominal pain2,075 reports
weight decreased1,816 reports
headache1,783 reports
Frequently Asked Questions
What is MESALAMINE used for?
MESALAMINE contains mesalamine. It is a tablet, delayed release taken oral. Consult your doctor for specific uses.
Is MESALAMINE a controlled substance?
MESALAMINE is not classified as a controlled substance by the DEA.
What is the generic name for MESALAMINE?
The generic name for MESALAMINE is mesalamine. There are 11 other brand versions of mesalamine.
What is the NDC code for MESALAMINE 1.2 g/1?
The NDC (National Drug Code) for MESALAMINE 1.2 g/1 is 0527-3012, listed by Lannett Company Inc..